Stanley Bower1, Jeff Lievense1, Ton Van Maris2, Jack T. Pronk3, Erik De Hulster2, Hans Van Dijken4, Ron Winkler5, Paola Branduardi6, and Danilo Porro6. (1) Tate and Lyle North America, Decator, IL, (2) Technical University Delft, Delft, Netherlands, (3) Department of Biotechnology, Delft University of Technology, Julianalaan 67, 2628 BC, Delft, Netherlands, (4) Bird Engineering B.V., Westfrankelandsedijk 1, Schiedam, 3115 HG, Netherlands, (5) Bird Engineering, Delft, Netherlands, (6) University Milan Bicoccia, Milan, Italy
Saccharomyces cerevisiae is a promising organism for the production of organic acids. It is well known and well accepted in the fermentation industry. It is reasonably tolerant to low pH. There is an exceptional tool box of genetic and genomic tools for manipulation of the yeast. Tate & Lyle has over the last dozen years, with a number of collaborators, developed production of lactic acid in S. cerevisiae. This work has been extended to the production of additional organic acids. The model for collaboration, metabolic targets, and production cost drivers will be discussed.